Sumin Bian
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 04, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
Journal: Journal of Crohn's & colitis
Published: March 02, 2019
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing.
Journal: Alimentary pharmacology & therapeutics
Published: May 22, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 12, 2018
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time.
Journal: Inflammatory bowel diseases
Published: November 16, 2017
Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.
Journal: Therapeutic drug monitoring
Published: June 02, 2017
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
Journal: Drug testing and analysis
Published: February 24, 2017
Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.
Journal: Alimentary pharmacology & therapeutics
Published: December 16, 2016
Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab.
Journal: The AAPS journal
Published: September 16, 2016
Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 12, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026